Skip to main content
Cenra Inc. logo

Cenra Inc. — Investor Relations & Filings

Ticker · 3716 ISIN · TW0003716007 TW Manufacturing
Filings indexed 399 across all filing types
Latest filing 2025-09-04 Regulatory Filings
Country TW Taiwan
Listing TW 3716

About Cenra Inc.

https://www.cenra.com/

Cenra Inc. is a diversified healthcare enterprise with a history dating back to 1952. The company operates across a comprehensive value chain encompassing research and development, manufacturing, commercial marketing, and long-term care services. Its extensive portfolio includes active pharmaceutical ingredients (APIs), human pharmaceuticals, animal health products, and consumer health brands such as dietary supplements and personal care items. With a global reach spanning over 60 markets, the organization utilizes nine production bases and more than ten specialized technology platforms to deliver integrated health solutions. Cenra Inc. focuses on high-barrier oncology medications, complex generics, and 505(b)(2) drug developments. By integrating scientific innovation with rigorous operational management, the company provides accessible medical care and health services designed to meet evolving needs across all life stages.

Recent filings

Filing Released Lang Actions
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as approval dates, shareholder meeting resolution date, and regulatory approval references. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory announcement about a corporate action (name change) rather than a financial report or detailed filing. It fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-09-04 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) regarding a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced, and no mention of financial results or management changes beyond the name change. The document is a regulatory announcement about a corporate action (name change) rather than a financial report or management change announcement. Given the nature and length, it fits best under Regulatory Filings (RNS) as a general regulatory announcement that does not fit other specific categories.
2025-09-03 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement regarding the change of the company's name from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as the approval date, shareholder meeting resolution date, and registration information. There is no financial data, no report attached or referenced, and no mention of financial results or management changes. The document is a regulatory announcement about a corporate name change, which fits best under Regulatory Filings (RNS) as it does not fit other specific categories like management changes (MANG) or capital changes (SHA). The document length is short (898 characters), and it is a factual announcement rather than a report or presentation.
2025-09-02 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) regarding a company name change from "中化投資控股股份有限公司" to "中化控股股份有限公司". It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory announcement about a corporate name change, which fits best under Regulatory Filings (RNS) as it does not match any other specific category and is a general compliance disclosure.
2025-09-01 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 95% confidence The document is a short announcement (898 characters) about a company name change from '中化投資控股股份有限公司' to '中化控股股份有限公司'. It includes details such as the approval date, shareholder meeting resolution date, and regulatory approval number. There is no financial data, no report attached or referenced as being published, and no detailed financial or management information. The document is a regulatory announcement about a corporate name change, which does not fit into financial reports or detailed filings. It is best classified as a Regulatory Filing (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other categories.
2025-08-31 Chinese
公告本公司名稱由「中化投資控股股份有限公司」 更名為「中化控股股份有限公司」, 公告期間:114年07月09日至114年10月08日
Regulatory Filings Classification · 100% confidence The document is a public announcement from a listed company (3716 中化控股) regarding a change in the company name. It includes details such as the old and new company names, approval dates, and shareholder meeting resolution dates. There is no financial data, no report attached or referenced, and no mention of financial results or management changes beyond the name change. This type of announcement fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other specific categories.
2025-08-30 Chinese

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.